Cargando…
Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy
Gonadotropin-releasing hormone (GnRH) therapy has been known to increase risks of major adverse cardiovascular and cerebrovascular events (MACCEs). Herein, we aim to estimate whether regular use of aspirin attenuates risks of MACCEs in prostate cancer patients receiving GnRHs. Using Taiwanese Nation...
Autores principales: | Chang, Wei-Ting, Hong, Chon-Seng, Hsieh, Kun-Lin, Chen, Yi-Chen, Ho, Chung−Han, Shih, Jhih-Yuan, Kan, Wei-Chih, Chen, Zhih-Cherng, Lin, You-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511956/ https://www.ncbi.nlm.nih.gov/pubmed/36172150 http://dx.doi.org/10.3389/fonc.2022.952370 |
Ejemplares similares
-
Association of Gonadotropin-Releasing Hormone Therapies With Venous Thromboembolic Events in Patients With Prostate Cancer: A National Cohort Study
por: Hong, Chon-Seng, et al.
Publicado: (2022) -
Increased Risk of Pneumonia in Patients Receiving Gonadotropin-Releasing Hormone Agonists for Prostate Cancer
por: Chung, Shiu-Dong, et al.
Publicado: (2014) -
Right ventricular expression of NT‐proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension
por: Chang, Wei‐Ting, et al.
Publicado: (2021) -
Deletion of MicroRNA-21 Impairs Neovascularization Following Limb Ischemia: From Bedside to Bench
por: Chang, Wei-Ting, et al.
Publicado: (2022) -
Growth differentiation factor-15 levels in the blood around the
pulmonary artery is associated with hospitalization for heart failure in
patients with pulmonary arterial hypertension
por: Chang, Wei-Ting, et al.
Publicado: (2020)